Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In this study, we investigated the cytolytic activity of peripheral blood T-cells (PBT) obtained from nine patients with primary lung cancer treated by surgical adjuvant adoptive immunotherapy (AIT) with lymphokine-activated killer cells and low-dose recombinant interleukin 2 at the time of rebound lymphocytosis (24-48 h after AIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP763701.RAjo_La389yCxdTrXnpUKz5wt2V5RGBsoejqr-AsMVDoU130_assertion description "[In this study, we investigated the cytolytic activity of peripheral blood T-cells (PBT) obtained from nine patients with primary lung cancer treated by surgical adjuvant adoptive immunotherapy (AIT) with lymphokine-activated killer cells and low-dose recombinant interleukin 2 at the time of rebound lymphocytosis (24-48 h after AIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP763701.RAjo_La389yCxdTrXnpUKz5wt2V5RGBsoejqr-AsMVDoU130_provenance.
• NP662161.RAVxBOB1xfjywDvRUb3uk1_CuD1hGNJuy6eTjyGQtDTmo130_assertion description "[In this study, we investigated the cytolytic activity of peripheral blood T-cells (PBT) obtained from nine patients with primary lung cancer treated by surgical adjuvant adoptive immunotherapy (AIT) with lymphokine-activated killer cells and low-dose recombinant interleukin 2 at the time of rebound lymphocytosis (24-48 h after AIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP662161.RAVxBOB1xfjywDvRUb3uk1_CuD1hGNJuy6eTjyGQtDTmo130_provenance.
• NP253556.RAAS93mdffLZPyN51v4mvcqoGrGG2wGCUKZiQAHaa9HU0130_assertion description "[In this study, we investigated the cytolytic activity of peripheral blood T-cells (PBT) obtained from nine patients with primary lung cancer treated by surgical adjuvant adoptive immunotherapy (AIT) with lymphokine-activated killer cells and low-dose recombinant interleukin 2 at the time of rebound lymphocytosis (24-48 h after AIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP253556.RAAS93mdffLZPyN51v4mvcqoGrGG2wGCUKZiQAHaa9HU0130_provenance.
• NP908733.RAotTjF_kePfzNRuTEeYtle6gQGi64FP_Tculplu3xNVU130_assertion description "[In this study, we investigated the cytolytic activity of peripheral blood T-cells (PBT) obtained from nine patients with primary lung cancer treated by surgical adjuvant adoptive immunotherapy (AIT) with lymphokine-activated killer cells and low-dose recombinant interleukin 2 at the time of rebound lymphocytosis (24-48 h after AIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP908733.RAotTjF_kePfzNRuTEeYtle6gQGi64FP_Tculplu3xNVU130_provenance.
• NP247557.RAK3n2eTXVog0TNfirikKJaoqPbSx-HKXE5werpFf-Ql0130_assertion description "[In this study, we investigated the cytolytic activity of peripheral blood T-cells (PBT) obtained from nine patients with primary lung cancer treated by surgical adjuvant adoptive immunotherapy (AIT) with lymphokine-activated killer cells and low-dose recombinant interleukin 2 at the time of rebound lymphocytosis (24-48 h after AIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247557.RAK3n2eTXVog0TNfirikKJaoqPbSx-HKXE5werpFf-Ql0130_provenance.
• NP410117.RAWeK6XqPmAZeudyF3ZT5Cmg580wLodBA6xsM_MvybUQA130_assertion description "[In this study, we investigated the cytolytic activity of peripheral blood T-cells (PBT) obtained from nine patients with primary lung cancer treated by surgical adjuvant adoptive immunotherapy (AIT) with lymphokine-activated killer cells and low-dose recombinant interleukin 2 at the time of rebound lymphocytosis (24-48 h after AIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP410117.RAWeK6XqPmAZeudyF3ZT5Cmg580wLodBA6xsM_MvybUQA130_provenance.
• NP718505.RAtPTxnMUzJ4nYmB8BvsoSxSJ7IrG_MjRVpcqsk6up1u4130_assertion description "[In this study, we investigated the cytolytic activity of peripheral blood T-cells (PBT) obtained from nine patients with primary lung cancer treated by surgical adjuvant adoptive immunotherapy (AIT) with lymphokine-activated killer cells and low-dose recombinant interleukin 2 at the time of rebound lymphocytosis (24-48 h after AIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718505.RAtPTxnMUzJ4nYmB8BvsoSxSJ7IrG_MjRVpcqsk6up1u4130_provenance.
• NP614241.RAvdoaLpq8L_teUp-EY6dtZtSdSEUiaIGwEu-fzeyrLyU130_assertion description "[In this study, we investigated the cytolytic activity of peripheral blood T-cells (PBT) obtained from nine patients with primary lung cancer treated by surgical adjuvant adoptive immunotherapy (AIT) with lymphokine-activated killer cells and low-dose recombinant interleukin 2 at the time of rebound lymphocytosis (24-48 h after AIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614241.RAvdoaLpq8L_teUp-EY6dtZtSdSEUiaIGwEu-fzeyrLyU130_provenance.
• NP795389.RA9YVyNEkGAceoHPcNGSKf6cKW1JiHTFJl1nu3vDNT52k130_assertion description "[In this study, we investigated the cytolytic activity of peripheral blood T-cells (PBT) obtained from nine patients with primary lung cancer treated by surgical adjuvant adoptive immunotherapy (AIT) with lymphokine-activated killer cells and low-dose recombinant interleukin 2 at the time of rebound lymphocytosis (24-48 h after AIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP795389.RA9YVyNEkGAceoHPcNGSKf6cKW1JiHTFJl1nu3vDNT52k130_provenance.
• assertion description "[In this study, we investigated the cytolytic activity of peripheral blood T-cells (PBT) obtained from nine patients with primary lung cancer treated by surgical adjuvant adoptive immunotherapy (AIT) with lymphokine-activated killer cells and low-dose recombinant interleukin 2 at the time of rebound lymphocytosis (24-48 h after AIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In this study, we investigated the cytolytic activity of peripheral blood T-cells (PBT) obtained from nine patients with primary lung cancer treated by surgical adjuvant adoptive immunotherapy (AIT) with lymphokine-activated killer cells and low-dose recombinant interleukin 2 at the time of rebound lymphocytosis (24-48 h after AIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In this study, we investigated the cytolytic activity of peripheral blood T-cells (PBT) obtained from nine patients with primary lung cancer treated by surgical adjuvant adoptive immunotherapy (AIT) with lymphokine-activated killer cells and low-dose recombinant interleukin 2 at the time of rebound lymphocytosis (24-48 h after AIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In this study, we investigated the cytolytic activity of peripheral blood T-cells (PBT) obtained from nine patients with primary lung cancer treated by surgical adjuvant adoptive immunotherapy (AIT) with lymphokine-activated killer cells and low-dose recombinant interleukin 2 at the time of rebound lymphocytosis (24-48 h after AIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP492437.RAyz1qZVnuVKJD-tn9mO0imkrWo9OjP7M5Q3g_uYLNjf4130_assertion description "[In this study, we investigated the cytolytic activity of peripheral blood T-cells (PBT) obtained from nine patients with primary lung cancer treated by surgical adjuvant adoptive immunotherapy (AIT) with lymphokine-activated killer cells and low-dose recombinant interleukin 2 at the time of rebound lymphocytosis (24-48 h after AIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP492437.RAyz1qZVnuVKJD-tn9mO0imkrWo9OjP7M5Q3g_uYLNjf4130_provenance.
• NP493045.RA-SmOz43q2TLY77l0VsssmkuoRHriOPT0tIeAwiuu6Qc130_assertion description "[In this study, we investigated the cytolytic activity of peripheral blood T-cells (PBT) obtained from nine patients with primary lung cancer treated by surgical adjuvant adoptive immunotherapy (AIT) with lymphokine-activated killer cells and low-dose recombinant interleukin 2 at the time of rebound lymphocytosis (24-48 h after AIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP493045.RA-SmOz43q2TLY77l0VsssmkuoRHriOPT0tIeAwiuu6Qc130_provenance.
• NP492809.RAJVMy5ZYFLrWS6e2lp7BwGGd7BBhaiL9MkK7y3h_8qxQ130_assertion description "[In this study, we investigated the cytolytic activity of peripheral blood T-cells (PBT) obtained from nine patients with primary lung cancer treated by surgical adjuvant adoptive immunotherapy (AIT) with lymphokine-activated killer cells and low-dose recombinant interleukin 2 at the time of rebound lymphocytosis (24-48 h after AIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP492809.RAJVMy5ZYFLrWS6e2lp7BwGGd7BBhaiL9MkK7y3h_8qxQ130_provenance.
• NP780054.RAFN4R-QD-el4nG0pe0XFMj60ovTo-_JFJiQv-lEd61aY130_assertion description "[In this study, we investigated the cytolytic activity of peripheral blood T-cells (PBT) obtained from nine patients with primary lung cancer treated by surgical adjuvant adoptive immunotherapy (AIT) with lymphokine-activated killer cells and low-dose recombinant interleukin 2 at the time of rebound lymphocytosis (24-48 h after AIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP780054.RAFN4R-QD-el4nG0pe0XFMj60ovTo-_JFJiQv-lEd61aY130_provenance.
• NP780052.RA-lM3tddqTHMa07ZFZe-uZwgVuLNvr1lpe_EzC7eglEU130_assertion description "[In this study, we investigated the cytolytic activity of peripheral blood T-cells (PBT) obtained from nine patients with primary lung cancer treated by surgical adjuvant adoptive immunotherapy (AIT) with lymphokine-activated killer cells and low-dose recombinant interleukin 2 at the time of rebound lymphocytosis (24-48 h after AIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP780052.RA-lM3tddqTHMa07ZFZe-uZwgVuLNvr1lpe_EzC7eglEU130_provenance.
• NP780053.RA_hLtYlbtzRMx7hzbAyGqJD4qCQ9hAiSteaNBOB4pgpE130_assertion description "[In this study, we investigated the cytolytic activity of peripheral blood T-cells (PBT) obtained from nine patients with primary lung cancer treated by surgical adjuvant adoptive immunotherapy (AIT) with lymphokine-activated killer cells and low-dose recombinant interleukin 2 at the time of rebound lymphocytosis (24-48 h after AIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP780053.RA_hLtYlbtzRMx7hzbAyGqJD4qCQ9hAiSteaNBOB4pgpE130_provenance.